Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 155, Issue 1, Pages 3-13
Publisher
Wiley
Online
2011-08-03
DOI
10.1111/j.1365-2141.2011.08807.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The coming of age of microRNA for B cell lymphomas
- (2011) Rebecca L Auer HISTOPATHOLOGY
- A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma
- (2011) Nianxi Zhao et al. JOURNAL OF NANOBIOTECHNOLOGY
- Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals
- (2010) Erik W. Orava et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- The prognostic and functional role of microRNAs in acute myeloid leukemia
- (2010) G. Marcucci et al. BLOOD
- Targeted Blockage of Signal Transducer and Activator of Transcription 5 Signaling Pathway with Decoy Oligodeoxynucleotides Suppresses Leukemic K562 Cell Growth
- (2010) Xiaozhong Wang et al. DNA AND CELL BIOLOGY
- Oligonucleotide delivery in cancer therapy
- (2010) Giuseppe De Rosa et al. Expert Opinion on Drug Delivery
- Hypoxia-Inducible Factor-1 α Expression Predicts Superior Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2010) Andrew M. Evens et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: A mini-review
- (2010) Dan Peer JOURNAL OF CONTROLLED RELEASE
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia
- (2010) Prabodhika R. Mallikaratchy et al. NUCLEIC ACIDS RESEARCH
- Advances in Aptamers
- (2010) Muhammad Ali Syed et al. OLIGONUCLEOTIDES
- Cell-Specific Aptamer-Mediated Targeted Drug Delivery
- (2010) Jiehua Zhou et al. OLIGONUCLEOTIDES
- Review of the Safety and Feasibility of Rapid Infusion of Rituximab
- (2010) Jill Atmar Journal of Oncology Practice
- Therapeutic MicroRNA Strategies in Human Cancer
- (2009) Chunsheng Li et al. AAPS Journal
- RNA Interference: From Basic Research to Therapeutic Applications
- (2009) Jens Kurreck ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders
- (2009) M.F. Benner et al. BRITISH JOURNAL OF DERMATOLOGY
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- Molecular Assembly of an Aptamer-Drug Conjugate for Targeted Drug Delivery to Tumor Cells
- (2009) Yu-Fen Huang et al. CHEMBIOCHEM
- A liposome-based nanostructure for aptamer directed delivery
- (2009) Huaizhi Kang et al. CHEMICAL COMMUNICATIONS
- Disease-specific biomarker discovery by aptamers
- (2009) Henning Ulrich et al. CYTOMETRY PART A
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Ligand-based targeted therapy for cancer tissue
- (2009) Manasi Das et al. Expert Opinion on Drug Delivery
- RNA interference as an anticancer therapy: a patent perspective
- (2009) Derek M Dykxhoorn EXPERT OPINION ON THERAPEUTIC PATENTS
- Aptamers as inhibitors of target proteins
- (2009) S Missailidis et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- 5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen
- (2009) Susan O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses
- (2009) Jorge E. Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial of AEG35156 X-Linked Inhibitor of Apoptosis Protein Antisense Oligonucleotide Combined With Idarubicin and Cytarabine in Patients With Relapsed or Primary Refractory Acute Myeloid Leukemia
- (2009) Aaron D. Schimmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells
- (2009) Peng Zhang et al. LABORATORY INVESTIGATION
- The role of microRNA in human leukemia: a review
- (2009) S Yendamuri et al. LEUKEMIA
- Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways
- (2009) W-L Zhao LEUKEMIA
- Molecular recognition of acute myeloid leukemia using aptamers
- (2009) K Sefah et al. LEUKEMIA
- Targeted Delivery of Antisense Oligodeoxynucleotide by Transferrin Conjugated pH-Sensitive Lipopolyplex Nanoparticles: A Novel Oligonucleotide-Based Therapeutic Strategy in Acute Myeloid Leukemia
- (2009) Yan Jin et al. MOLECULAR PHARMACEUTICS
- Applications of aptamers in cancer cell biology
- (2008) Joseph A. Phillips et al. ANALYTICA CHIMICA ACTA
- Lack of toxicity of a STAT3 decoy oligonucleotide
- (2008) Malabika Sen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
- (2008) E RAYBURN et al. DRUG DISCOVERY TODAY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started